STOCK TITAN

Claritev Corp (CTEV) director granted 8,977 restricted stock units in new award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Klapstein Julie D reported acquisition or exercise transactions in this Form 4 filing.

Claritev Corp director Julie D. Klapstein received a grant of 8,977 shares of Class A common stock in the form of restricted stock units. The award was granted at no cash cost per share and increases her direct holdings to 24,611 shares.

The restricted stock units vest on the earlier of one year from the grant date or the next regularly scheduled annual stockholder meeting, provided she continues serving through that date. If she resigns voluntarily without cause before then, the units vest on a pro rata basis according to days of service.

Positive

  • None.

Negative

  • None.
Insider Klapstein Julie D
Role null
Type Security Shares Price Value
Grant/Award Class A common stock 8,977 $0.00 --
Holdings After Transaction: Class A common stock — 24,611 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSUs granted 8,977 shares Restricted stock units of Class A common stock granted to director
Post-transaction holdings 24,611 shares Total Class A common stock held directly after grant
Grant price $0.0000 per share Reported transaction price for the RSU award
Transaction date 2026-04-29 Date of RSU grant to director
restricted stock units financial
"Represents restricted stock units which vest on the earlier of the one-year anniversary of the grant date"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vesting date financial
"subject to continued service through the vesting date; provided, however, that the restricted stock units vest pro rata"
annual meeting of stockholders financial
"vest on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders"
voluntary resignation financial
"in the event of a voluntary resignation other than when grounds for termination for cause exist"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Klapstein Julie D

(Last)(First)(Middle)
C/O CLARITEV CORPORATION
7900 TYSONS ONE PLACE, SUITE 400

(Street)
MCLEAN VIRGINIA 22102

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Claritev Corp [ CTEV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A common stock04/29/2026A(1)8,977A$024,611D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units which vest on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the issuer, subject to continued service through the vesting date; provided, however, that the restricted stock units vest pro rata based on the number of days of service provided to the issuer in the event of a voluntary resignation other than when grounds for termination for cause exist.
Remarks:
/s/ Kent Bartholomew, attorney-in-fact05/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Claritev Corp (CTEV) report for Julie D. Klapstein?

Claritev Corp reported that director Julie D. Klapstein received 8,977 restricted stock units of Class A common stock. These units were granted as equity compensation, not purchased in the market, and were recorded as an acquisition with no cash price per share.

How many Claritev Corp (CTEV) shares does Julie D. Klapstein hold after this Form 4?

After the grant, Julie D. Klapstein directly holds 24,611 shares of Claritev Corp Class A common stock. This total includes the 8,977 restricted stock units awarded in the transaction, reflecting her updated equity position as a company director.

When do Julie D. Klapstein’s new Claritev (CTEV) restricted stock units vest?

The restricted stock units vest on the earlier of one year from the grant date or the next regularly scheduled annual meeting of stockholders. Vesting is conditioned on her continued service with Claritev Corp through that applicable vesting date.

What happens to Claritev (CTEV) RSUs if Julie D. Klapstein resigns early?

If she voluntarily resigns before vesting, and there are no grounds for termination for cause, the restricted stock units vest on a pro rata basis. The vested portion is calculated according to the number of days of service provided to Claritev Corp before resignation.

Did Julie D. Klapstein buy or sell Claritev Corp (CTEV) shares on the market?

She did not buy or sell shares on the open market. The Form 4 shows an acquisition coded as a grant or award, with 8,977 restricted stock units granted at a reported price of $0.0000 per share as equity-based compensation.